Swipha manufactures sulfadoxine-pyrimethamine, which is a significant drug in the fight against malaria. According to an announcement on August 21, 2024, Swipha achieved WHO prequalification for sulfadoxine-pyrimethamine, marking a crucial step in global malaria control.
In summary:
- Drug: Sulfadoxine-pyrimethamine
- Manufacturer: Swipha
- Significance: Key medication in the fight against malaria, with Swipha achieving WHO prequalification.
